In people with relapsing forms of multiple sclerosis (MS) treated with Ocrevus (ocrelizumab), levels of B-cells can help to predict the risk of progression independent of relapse activity, a new stud… [+4742 chars]
B-cell levels can predict PIRA risk in relapsing MS patients on Ocrevus - Multiple Sclerosis News Today
Levels of B-cells can help to predict the risk of disability progression independent of relapse activity in relapsing MS patients on Ocrevus.
By:Marisa Wexler, MS
Source:Multiple Sclerosis News Today
Published:
Related News
Scientists shed new light on the brain’s role in heart attack - NPR
Researchers discovered a feedback loop between nerve cells, the immune system and the heart. They think it shows promise as a target for future therapies.
NPR•Esther Landhuis
US Pediatricians Give Middle Finger to RFK Jr., Issue Their Own Vaccine Recommendations - Gizmodo
The American Academy of Pediatrics and 12 other medical groups are recommending the same childhood shots once endorsed by the CDC.
Gizmodo.com•Ed Cara
What to know about the deadly Nipah virus, amid outbreak in India - The Washington Post
Some airports in Asia are on alert after confirmed cases in West Bengal of the Nipah virus, which has no cure. South Asia sees outbreaks nearly every year.
The Washington Post•Sammy Westfall